WiCell Teams with Agilent Technologies to Offer High-Resolution CGH+SNP Microarray Service
December 5, 2012
Agilent Technologies Inc. (NYSE: A) and WiCell, a world leader in the cytogenetic testing of mouse and human embryonic stem cells and induced pluripotent stem cells, today announced that WiCell is now offering comparative genomic hybridization plus single nucleotide polymorphism microarray analysis using the Agilent SurePrint G3 Human Genome CGH+SNP Microarray. Unlike previous assays that [...]
Sartorius Stedim Biotech Launches Sartoguard NF Prefilter Series
December 5, 2012
Goettingen, Germany and Aubagne, France, – Sartorius Stedim Biotech (SSB), a leading international pharma supplier, has launched the Sartoguard NF prefilter series, completing its range of Sartoguard prefilters. These new prefilters feature a unique combination of high performance polyethersulfone (PES) membranes and highly innovative nanofleece technology. This is the first time that PES nanofleece material [...]
December 5, 2012
Harvard Apparatus, the world leader in syringe pumps, announces the new Harvard Peristaltic Pump series. These remote-controlled, programmable peristaltic pumps offer unparalleled accuracy, reproducibility, and ease of use over a broad range of flow rates. Key Benefits: • Remote-controlled design and sealed pump head make this pump ideal for use in incubators and fume hoods [...]
Biocartis announces commercial launch of a new biomarker analysis platform
December 5, 2012
Accurate and fast validation of biomarkers; increasing efficiency in Research and Drug Development DMAT is an innovative and integrated detection platform for high quality biomarker analysis. It enables accelerated development of multiplex assays where several biomarkers can be analyzed at the same time. DMAT dramatically reduces hands-on time and allows users to perform bioassays far [...]
Pressure BioSciences, Inc. Appoints Conrad F. Mir as Chief Financial Officer
December 5, 2012
SOUTH EASTON, Mass., -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced that Mr. Conrad F. Mir has joined the Company as its chief financial officer ("CFO"), effective immediately. Mr. Mir has over twenty years experience in investment banking, financial structuring, and corporate reengineering. He has served in various executive management roles [...]
December 5, 2012
ALMSCO International (Llantrisant, UK) has announced the launch of its new version of TargetView™, a software package for compound identification following GC/MS analysis. Capable of detecting and identifying both target and ‘unknown’ compounds in complex GC/MS chromatograms, for either trace-level work or for routine screening, the software has been designed for all GC/MS analysts irrespective [...]
Higher Volume 96-format Sample Storage Tubes
December 5, 2012
Micronic has launched a new 2.00ml storage tube that uniquely combines higher sample storage capacity and absolute sample traceability in an industry-standard 96-tube rack format. For organizations in the life sciences industry, such as biobanks or biotechnology and pharmaceutical research companies - assured high integrity storage and ease of handling of each sample is critical. [...]
December 5, 2012
Roche (SIX: RO, ROG; OTCQX: RHHBY) and the Innovative Medicines Initiative (IMI) announced today the launch of StemBANCC, a new academic–industry partnership that unites ten pharmaceutical companies and 23 academic institutions. Initiated and coordinated by Roche and managed by Oxford University, StemBANCC aims to use human induced pluripotent stem cells as research tools for drug [...]
ANNOVAR Appoints BIOBASE for Commercial Distribution
December 5, 2012
BIOBASE today announced a new agreement with the University of Southern California and The Children’s Hospital of Philadelphia. The agreement covers the exclusive worldwide marketing and distribution of the ANNOVAR tool to commercial users. ANNOVAR enables the annotation of genomic variants on a variety of species including human. It is an efficient software tool for [...]
Predictive Biosciences Announces Next-Generation Sequencing Assay for p53
December 5, 2012
LEXINGTON, MA – Predictive Biosciences, an innovative developer of molecular diagnostic tests, today announced that the Company has developed a new next-generation sequencing (NGS) assay for the TP53 gene (encoding the p53 protein) that will enhance the clinical performance of its bladder cancer assay. The new CertNDxTM Bladder Cancer Assay incorporating TP53 is expected to [...]

